Therapeutically targeting tumor microenvironment–mediated drug resistance in estrogen receptor–positive breast cancer
Whole-transcriptome sequencing of ER+ breast cancer cell lines (MCF-7 and T47D) treated with the anti-estrogen fulvestrant +/- fibroblast growth factor (FGF2).
Organism: Homo sapiens
Data Type: RNA sequencing
Accession: PRJNA389319
Related publication